Biden schlägt eine Kostenübernahme für Medikamente zur Gewichtsreduktion durch Medicare und Medicaid vor

President Biden’s proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump’s administration. Julie Rovner, the chief Washington correspondent for Kaiser Health News, joins CBS News with more.